CLADRIBINE REGIMEN FOR USE INTREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS

摘要

The present invention relates to the use of specific oral dosings, specific oral dosage forms and/or specific oral dose regimens comprising Cladribine for the treatment of progressive forms of Multiple Sclerosis, especially Primary Progressive Multiple Sclerosis and/or Secondary Progressive Multiple Sclerosis, and methods of treatment based thereon.